Cancer Drug New Prostate – New Drug for Prostate Cancer

August 15, 2009 by  
Filed under Prostate Cancer News

Prostate cancer is one of those anomalous disease about which so little is known and even littler is understood. The specific cause of prostate cancer, for example, is not known – all that is available are a number of risk factors that contribute to prostate cancer incidence, which hardly cut it when you come to think of it. As a result perhaps, they don’t have a definitive cure for the disease yet – just various treatments, therapies and medications that help in some way or the other in the interventions for the disease.

But newer methods for treating the disease are springing up all the time. There are new therapies, for instance, that employ new drugs and new procedures, some improving on old ones, and others just being so radically different and innovative that they are quite stunning.

One new drug for prostate cancer treatment follows the concept of hormonal therapy – inhibiting the activity of androgens like testosterone that help drive prostate cancer tumor growth. Existing anti-androgens attempt to “shut down the factory that produces the hormones, but the new drug blocks the receptors for those androgens on the tumor cells,” according to Dr. Howard I. Scher, chief of the genitourinary oncology service at Memorial Sloan-Kettering Cancer Center in New York City and co-author of a report to be published online by the journal Science.

The drug, yet referred to as MDV3100 has been requested for large-scale trial that would be international in scope. The application was submitted to the FDA by Medivation Inc., the California-based biopharmaceutical company that has it licensed. They have a lot of confidence that the trial will lead to FDA approval of the drug for clinical use.

And while all of that is going on, a new immune system treatment for advanced prostate cancer has been realized to be safe and effective enough to begin U.S. sales, having already been approved by the FDA. A panel of FDA advisors concluded the Provenge helps to prolong the lives of patients suffering from advanced stage prostate cancer, a phase of the carcinoma that is most difficult to treat. There were natural apprehensions about getting the drug approved, but they were apparently baseless.

A trial at the Mayo Clinic also has yielded some encouraging results for a new experimental drug that was tested on some patients, two of which had cancers that were inoperable. After a while, they made remarkable enough discoveries to go public about it. You can get your hopes up, because these medications will soon hit the drugstores and you can soon get them with a prescription from your doctor, and get saved from prostate cancer.

No Related Articles.

Speak Your Mind

Tell us what you're thinking... !

s